Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Follow the Molecule is a private U.S.-based drug development consulting company focused on clinical sciences and smart drug development strategy, particularly in central nervous system programs. The company appears to advise biopharma sponsors on translating preclinical findings into human studies, assessing target engagement, optimizing dose and dosage forms, and designing clinical development strategies. Publicly available information links the business closely to Larry Ereshefsky, PharmD, who is identified as owner and chief scientific officer. Rather than operating a disclosed proprietary therapeutic pipeline, the company functions primarily as an external expert advisory and consulting organization serving drug developers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Follow the Molecule.